臺大醫院-腫瘤醫學部;臺大醫學院-癌症研究中心;Camidge, RossRossCamidgeCappuzzo, FedericoFedericoCappuzzoGo, JowellJowellGoIsaacson, JeffreyJeffreyIsaacsonLitten, JasonJasonLittenPark, KeunchilKeunchilParkSpigel, David R.David R.SpigelSpira, AlexanderAlexanderSpiraVergnenegre, AlainAlainVergnenegreWolf, JuergenJuergenWolfYang, James Chih-HsinJames Chih-HsinYangMok, TonyTonyMok2017-07-102018-07-092017-07-102018-07-092015http://ntur.lib.ntu.edu.tw//handle/246246/281035T790MrociletinibEGFRNSCLCTIGER-1: A Phase 2/3 Study of First Line Rociletinib or Erlotinib in EGFR-Mutant NSCLC